Andrew Powell, JD
Mr. Powell, a former biotech executive, will moderate the Saturday afternoon panel discussion on how patients can participate in the research and development of new treatments. Among his post-biotech projects, Mr. Powell serves as HF’s Industry Outreach Officer.
Mr. Powell spent 25 years in the biotech industry. Trained as a lawyer, he worked in various companies that developed innovative drugs. He has also been active in expanding access to healthcare by serving as an advisor to the WIN and Red Segura non-profit healthcare initiatives in Senegal and Honduras, and by working with the Hypersomnia Foundation to engage drug companies in developing treatments for this rare neurological disorder.
He serves on the boards of Aclaris, Inc., a NASDAQ listed biotechnology company, Cure Network Ventures, the enterprise arm of the Gladstone Institutes at the University of California, and NeuDrive Limited, a U.K. company developing technology to disrupt drug development and diagnostics. He is also a Member of the Band of Angels, a group focused on funding and mentoring technology driven start-ups in the San Francisco Bay Area.
Mr. Powell attended Winchester College in England, is a Morehead Scholar from the University of North Carolina at Chapel Hill, and earned a Juris Doctor degree at Stanford.